Novo Nordisk A/S ADR buy UBS Group AG
Start price
08.01.25
/
50%
€83.20
Target price
08.01.26
-
Performance (%)
-49.76%
Price
16:24
€40.70
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Novo Nordisk A/S ADR is performing very badly with a performance of -49.76%. A total of €1.10 was paid as dividends for this prediction. This prediction currently runs until 08.01.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | -3.095% | -3.095% |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by UBS_Group_AG for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) was upgraded by analysts at UBS Group AG from a "sell" rating to a "buy" rating.
Ratings data for NVO provided by MarketBeat